Today's Rundown Belldegrun's Vida raises $600M biotech investment fund Chipscreen upsizes IPO as investors flock to China's STAR Market Adaptimmune R&D chief leaves at dawn of critical trial Amicus shares early look at Batten disease gene therapy Novo, e-therapeutics extend Type 2 diabetes research pact to include new genomics tech Bayer teams up with AI firm Sensyne Health to mine NHS data for its heart disease pipeline Reversing sickle cell disease with CRISPR-edited stem cells Featured Story | | | Thursday, August 1, 2019 Arie Belldegrun’s Vida Ventures has put together a $600 million fund, moving the total raised by the VC shop in its two-year history up toward $1 billion. |
|
|
Top Stories Thursday, August 1, 2019 Shenzhen Chipscreen Biosciences upsized its IPO after the shares reserved for individuals were almost 3,000 times oversubscribed. The Chinese drug developer expects to raise RMB 1 billion ($145 million), 27% more than it initially aimed to generate. Thursday, August 1, 2019 Rafael Amado has handed in his notice at Adaptimmune. The R&D chief is set to leave Adaptimmune in less than two weeks, triggering a search for a new clinical leader. Thursday, August 1, 2019 Amicus Therapeutics has shared interim data on a Batten disease gene therapy it acquired last year. The study has generated early evidence that the gene therapy may stabilize the motor and language function of children with the rare genetic disorder. Thursday, August 1, 2019 Novo Nordisk and e-therapeutics have opted to extend their drug discovery collaboration launched last December in Type 2 diabetes to incorporate a new approach to genomic data. Wednesday, July 31, 2019 Bayer tapped Sensyne Health to sift through patient data from the U.K. National Health Service, mine it for insights using its artificial intelligence platforms and apply the findings to its cardiovascular disease pipeline. Wednesday, July 31, 2019 Scientists at Fred Hutchinson Cancer Research Center used CRISPR-Cas9 to boost the production of fetal hemoglobin to treat blood disorders. By targeting a specific population of stem cells, they were able to slash the number of cells required for transplantation by 10-fold in monkey studies. Resources Sponsored by: Patheon, by Thermo Fisher Scientific Patheon, part of Thermo Fisher Scientific, offers advanced API manufacturing technologies such as continuous processing and continuous analytics to deliver high-quality products with well-defined features to meet your timelines and volume requirements. Sponsored by: ICON Understanding the challenges for formulary decision makers and manufacturers. Sponsored by: Veeva This white paper details how leveraging new reporting capabilities, live UAT feedback sessions, and an agile design approach to study builds will save them time and money. Sponsored by: BBK Worldwide The Study Voices survey challenges the myth that physicians won’t refer patients to clinical trials, and it identifies opportunities to engage physicians as partners in the enrollment process. Sponsored by: Cambrex The highest number of NCEs approved by the FDA…the fastest growing small molecule clinical pipeline reported in 20 years…these are exciting times for our industry. Sponsored by: Reprints Desk, Inc. Cut your research time in half - with an easy-to-use app for scientists that combines full-featured reference management with integrated search and on-demand document delivery. Sponsored by: Almac Group Innovative Just in Time Manufacturing solution enables sponsors full late stage customisation of clinical trial materials Sponsored by: PwC How are employer activism strategies beginning to replace the cost-sharing of the past, and improve the health of the workforce? Sponsored by: XiltriX North America Find out in this article how your pharmaceutical organization can leverage IoT technologies and informatics integration to innovate and improve overall operational efficiencies. Sponsored by: Veradigm Patient demand for more information on their care is driving new e-prescribing regulations, and technology is evolving to help providers meet them. This report provides an overview of key areas where such regulation has emerged, and what it could mean for providers and healthcare IT companies. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Latin America Healthcare Compliance Certificate Program September 23-26, 2019 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register NOW and start Pre-Boot Camp Preparation! | 